Jay B. Lichter

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Leawood, KS
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jay B. Lichter
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jay B. Lichter

Form 4 holding 10%+ Owner

Janux Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,021,414
Estimated value
$135,208,277
Report date
13 Sep 2024
Price
$44.75
Ownership
By Avalon BioVentures SPV I, L.P.
Form 4 holding 10%+ Owner

Janux Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,959,175
Estimated value
$132,423,081
Report date
13 Sep 2024
Price
$44.75
Ownership
By Avalon Ventures XI, L.P.
Form 4 holding 10%+ Owner

Janux Therapeutics, Inc.

Security class
Common Stock
Shares / value
573,227
Estimated value
$25,651,908
Report date
13 Sep 2024
Price
$44.75
Ownership
By Avalon BioVentures I, LP
Form 4 holding 10%+ Owner

Janux Therapeutics, Inc.

Security class
Common Stock
Shares / value
7,000
Estimated value
$326,760
Report date
13 Sep 2024
Price
$46.68
Ownership
Direct
Form 4 holding Director

OTONOMY, INC.

Security class
Stock Option (right to buy)
Shares / value
27,500
Estimated value
Report date
21 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Janux Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
7,682
Estimated value
Report date
13 Sep 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jay B. Lichter

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .